Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
暂无分享,去创建一个
Johannes C. Klein | Stefan Vollmar | Rüdiger Hilker | R. Hilker | J. Klein | W. Heiss | S. Baudrexel | E. Kalbe | N. Diederich | R. Hilker | S. Vollmar | C. Eggers | S. Weisenbach | Simon Weisenbach | Wolf-Dieter Heiss | Elke Kalbe | Carsten Eggers | Carina Hohmann | S. Baudrexel | Nico J. Diederich | E. Kalbe | C. Hohmann | Carina Hohmann
[1] D J Brooks,et al. DLB and PDD boundary issues , 2007, Neurology.
[2] B. Schmand,et al. Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.
[3] Karl Herholz,et al. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease , 2004, NeuroImage.
[4] Keith A. Johnson,et al. Imaging amyloid deposition in Lewy body diseases , 2008, Neurology.
[5] Karl J. Friston,et al. Statistical parametric mapping , 2013 .
[6] Michael L. Kramer,et al. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] C. Rowe,et al. Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[8] N. Bohnen,et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.
[9] G. Glosser,et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.
[10] F. Mastaglia,et al. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease. , 2003, Movement disorders : official journal of the Movement Disorder Society.
[11] N. Bohnen,et al. Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia , 2006, Journal of Neurology.
[12] P. Hof,et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.
[13] E. Sariban,et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium , 1998, Bone Marrow Transplantation.
[14] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] R. Hilker,et al. Dementia in Parkinson disease , 2005, Neurology.
[16] H. Arai,et al. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies , 2000, Neurology.
[17] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[18] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[19] E. Perry,et al. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology , 1999, Journal of Neural Transmission.
[20] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[21] E. Perry,et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum , 2006, Neurology.
[22] Albert Gjedde,et al. Oxidative and Nonoxidative Metabolism of Excited Neurons and Astrocytes , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] A. Tröster,et al. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease , 2003, Journal of the International Neuropsychological Society.
[24] E. Tolosa,et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[25] A. Lees,et al. Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients , 2008, Acta Neuropathologica.
[26] W D Heiss,et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene , 2001, Annals of neurology.
[27] K Wienhard,et al. Estimation of Local Cerebral Glucose Utilization by Positron Emission Tomography of [18F]2-Fluoro-2-Deoxy-D-Glucose: A Critical Appraisal of Optimization Procedures , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] T. Suhara,et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET , 2009, Neuroscience Research.
[29] F. Mastaglia,et al. Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease , 2003 .
[30] M. Lercher,et al. PET functional parametric images of acetylcholine esterase activity without blood sampling , 2002 .
[31] J. Ashburner,et al. Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.
[32] Matthias Reimold,et al. [11C]PIB binding in Parkinson's disease dementia , 2008, NeuroImage.
[33] Dag Aarsland,et al. Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity? , 2004, Journal of geriatric psychiatry and neurology.
[34] J. Trojanowski,et al. Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses , 2003, Annals of the New York Academy of Sciences.
[35] E. Perry,et al. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems , 2008, Journal of Neural Transmission.
[36] C. Rowe,et al. Imaging β-amyloid burden in aging and dementia , 2007, Neurology.
[37] Dag Aarsland,et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. , 2004, Archives of neurology.
[38] Mark W. Woolrich,et al. Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.
[39] R. Martínez-Murillo,et al. Distribution of catecholaminergic afferent fibres in the rat globus pallidus and their relations with cholinergic neurons , 1998, Journal of Chemical Neuroanatomy.
[40] Peter Herscovitch,et al. Brain imaging using PET , 2002 .
[41] Michael L. Kramer,et al. Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.
[42] J. O'Brien,et al. Functional Imaging in Parkinson’s Disease and Dementia with Lewy Bodies , 2004, Journal of geriatric psychiatry and neurology.